213 related articles for article (PubMed ID: 21709195)
21. Molecular Targeting of the Human Epidermal Growth Factor Receptor-2 (HER2) Genes across Various Cancers.
Rubin E; Shan KS; Dalal S; Vu DUD; Milillo-Naraine AM; Guaqueta D; Ergle A
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256137
[TBL] [Abstract][Full Text] [Related]
22. HER3: Toward the Prognostic Significance, Therapeutic Potential, Current Challenges, and Future Therapeutics in Different Types of Cancer.
Majumder A
Cells; 2023 Oct; 12(21):. PubMed ID: 37947595
[TBL] [Abstract][Full Text] [Related]
23. [Risk modeling based on HER-2 related genes for bladder cancer survival prognosis assessment].
Liu HR; Peng X; Li SL; Gou X
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Oct; 55(5):793-801. PubMed ID: 37807731
[TBL] [Abstract][Full Text] [Related]
24. Rewiring of mitochondrial metabolism in therapy-resistant cancers: permanent and plastic adaptations.
Pendleton KE; Wang K; Echeverria GV
Front Cell Dev Biol; 2023; 11():1254313. PubMed ID: 37779896
[TBL] [Abstract][Full Text] [Related]
25. Nestin overexpression reduces the sensitivity of gastric cancer cells to trastuzumab.
Wei YC; Zhu JY; Wu J; Yu S; Li W; Zhu MX; Liu TS; Cui YH; Li Q
J Gastrointest Oncol; 2023 Aug; 14(4):1694-1706. PubMed ID: 37720426
[TBL] [Abstract][Full Text] [Related]
26. A comparative study of gastric adenocarcinoma HER2 IHC phenotype and mass spectrometry-based quantification.
Xu B; Chen H; Zhang J; Cong Y; Ning L; Chen L; Zhang Y; Zhang Y; Song Z; Meng Y; He L; Liao WL; Lu Y; Zhao F
Front Oncol; 2023; 13():1152895. PubMed ID: 37350943
[TBL] [Abstract][Full Text] [Related]
27. Comparison of survival outcomes according of patients with metastatic gastric cancer receiving trastuzumab with systemic chemotherapy.
Ha GY; Yang SH; Kang HJ; Lee HL; Kim J; Kim YJ; Yu HJ; Lee JI; Jin SH
Korean J Clin Oncol; 2020 Dec; 16(2):63-70. PubMed ID: 36945715
[TBL] [Abstract][Full Text] [Related]
28. Perioperative Tailored Treatments for Gastric Cancer: Times Are Changing.
Lavacchi D; Fancelli S; Buttitta E; Vannini G; Guidolin A; Winchler C; Caliman E; Vannini A; Giommoni E; Brugia M; Cianchi F; Pillozzi S; Roviello G; Antonuzzo L
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902306
[TBL] [Abstract][Full Text] [Related]
29. Human epidermal growth factor receptor-2 gene expression positivity determined by silver in situ hybridization/immunohistochemistry methods and associated factors in a cohort of Sri Lankan patients with gastric adenocarcinoma: a prospective study.
Subasinghe D; Acott N; Mahesh PKB; Sivaganesh S; Munasinghe S; Kumarasinghe MP; Samarasekera DN; Lokuhetty MDS
J Int Med Res; 2023 Feb; 51(2):3000605231154403. PubMed ID: 36814374
[TBL] [Abstract][Full Text] [Related]
30. The potential of mRNA expression evaluation in predicting HER2 positivity in gastroesophageal cancer.
Oliveira IM; Nicolau-Neto P; Fernandes PV; Lavigne TS; Neves PF; Tobar JC; Soares-Lima SC; Simão TA; Pinto LFR
Braz J Med Biol Res; 2022; 55():e12428. PubMed ID: 36383805
[TBL] [Abstract][Full Text] [Related]
31. Her-2 Targeted Therapy in Advanced Urothelial Cancer: From Monoclonal Antibodies to Antibody-Drug Conjugates.
Albarrán V; Rosero DI; Chamorro J; Pozas J; San Román M; Barrill AM; Alía V; Sotoca P; Guerrero P; Calvo JC; Orejana I; Pérez de Aguado P; Gajate P
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293515
[TBL] [Abstract][Full Text] [Related]
32. Phase II Study of Afatinib in Patients With Tumors With Human Epidermal Growth Factor Receptor 2-Activating Mutations: Results From the National Cancer Institute-Molecular Analysis for Therapy Choice ECOG-ACRIN Trial (EAY131) Subprotocol EAY131-B.
Bedard PL; Li S; Wisinski KB; Yang ES; Limaye SA; Mitchell EP; Zwiebel JA; Moscow JA; Gray RJ; Wang V; McShane LM; Rubinstein LV; Patton DR; Williams PM; Hamilton SR; Conley BA; Arteaga CL; Harris LN; O'Dwyer PJ; Chen AP; Flaherty KT
JCO Precis Oncol; 2022 Jul; 6():e2200165. PubMed ID: 35939768
[TBL] [Abstract][Full Text] [Related]
33. Evolution of predictive and prognostic biomarkers in the treatment of advanced gastric cancer.
Myer NM; Shitara K; Chung HC; Lordick F; Kelly RJ; Szabo Z; Cao ZA; Leong S; Ilson DH; Weichert W
J Cancer Res Clin Oncol; 2022 Aug; 148(8):2023-2043. PubMed ID: 35551464
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of Her-2 in Biopsy-Proven Urothelial Carcinoma Patients From Pakistan.
Chughtai A; Zafar G; Khalid F; Afzal S; Usman B; Chughtai AS
Cureus; 2022 Apr; 14(4):e23739. PubMed ID: 35509755
[TBL] [Abstract][Full Text] [Related]
35. The Impact of Tumor Mutation Burden on the Effect of Frontline Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2-Positive Advanced Gastric Cancers.
Kim HR; Ahn S; Jo H; Kim H; Hong J; Lee J; Lim HY; Kang WK; Kim ST
Front Oncol; 2021; 11():792340. PubMed ID: 34926309
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of Human Epidermal Growth Factor Receptor 2 Overexpression, Clinicopathological Characteristics, and Factors Affecting Survival in Gastric Cancer.
Celayir OM; Selcukbiricik F; Tanik C; Altuntas Y
Sisli Etfal Hastan Tip Bul; 2021; 55(2):224-231. PubMed ID: 34349600
[TBL] [Abstract][Full Text] [Related]
37. The Pyroptosis-Related Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Gastric Cancer.
Shao W; Yang Z; Fu Y; Zheng L; Liu F; Chai L; Jia J
Front Cell Dev Biol; 2021; 9():676485. PubMed ID: 34179006
[TBL] [Abstract][Full Text] [Related]
38. Molecular Oncology in Management of Colorectal Cancer.
Vemala RNG; Katti SV; Sirohi B; Manikandan D; Nandakumar G
Indian J Surg Oncol; 2021 Apr; 12(Suppl 1):169-180. PubMed ID: 33994743
[TBL] [Abstract][Full Text] [Related]
39. Targeting the PI3K and MAPK pathways to improve response to HER2-targeted therapies in HER2-positive gastric cancer.
Mezynski MJ; Farrelly AM; Cremona M; Carr A; Morgan C; Workman J; Armstrong P; McAuley J; Madden S; Fay J; Sheehan KM; Kay EW; Holohan C; Elamin Y; Rafee S; Morris PG; Breathnach O; Grogan L; Hennessy BT; Toomey S
J Transl Med; 2021 May; 19(1):184. PubMed ID: 33933113
[TBL] [Abstract][Full Text] [Related]
40. The expression and prognostic value of the epidermal growth factor receptor family in glioma.
Xu B; Huo Z; Huang H; Ji W; Bian Z; Jiao J; Sun J; Shao J
BMC Cancer; 2021 Apr; 21(1):451. PubMed ID: 33892666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
